Radiotherapy has been shown to induce the accumulation of myeloid-derived suppressive cells (MDSCs) and upregulate programmed death ligand 1 (PD-L1) expression in the tumour microenvironment, restricting its anti-tumour effect [75]. The gene discussed is CD274; the disease is neoplasm.